Literature DB >> 15599883

Thoughts about the classification of small vessel vasculitis.

Ronald J Falk1, J Charles Jennette.   

Abstract

The classification of small vessel vasculitis has markedly changed over the past 150 years. With the discovery of anti-neutrophil cytoplasmic autoantibodies (ANCA), renewed interest in the field has spawned investigations into the immunopathogenesis of small vessel vasculitis. This review will describe the historical basis of the classification of vasculitis, the current nosology based on the Chapel Hill Nomenclature for vasculitis and then both pathogenic and clinical reasons that support the use of the term "ANCA small vessel vasculitis" to describe the pauci-immune necrotizing small vessel vasculitides, including microscopic polyangiitis, Wegener's granulomatosis, the Churg-Strauss syndrome and pauci-immune necrotizing and crescentic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599883

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

Review 1.  Cutaneous vasculitis.

Authors:  Samina Hayat; Seth Mark Berney
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 2.  Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?

Authors:  B Hervier; M Hamidou; J Haroche; C Durant; A Mathian; Z Amoura
Journal:  Rheumatol Int       Date:  2011-07-30       Impact factor: 2.631

Review 3.  Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.

Authors:  Spyros A Papiris; Effrosyni D Manali; Ioannis Kalomenidis; Giorgios E Kapotsis; Anna Karakatsani; Charis Roussos
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

4.  Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus.

Authors:  Fang Su; Weiguo Xiao; Pingting Yang; Qingyan Chen; Xiaojie Sun; Tienan Li
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

5.  On the Wegener granulomatosis associated region on chromosome 6p21.3.

Authors:  Paweł Szyld; Peter Jagiello; Elena Csernok; Wolfgang L Gross; Joerg T Epplen
Journal:  BMC Med Genet       Date:  2006-03-09       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.